pioglitazone has been researched along with bq 123 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagami, T; Doi, T; Masuyama, T; Mori, Y; Naka, T; Ohyanagi, M; Sakoda, T; Tsujino, T | 1 |
| Campia, U; Cardillo, C; Matuskey, LA; Panza, JA; Tesauro, M | 1 |
1 trial(s) available for pioglitazone and bq 123
| Article | Year |
|---|---|
PPARĪ³ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia.
Topics: Biomarkers; C-Reactive Protein; Cross-Over Studies; District of Columbia; Double-Blind Method; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Fatty Acids, Nonesterified; Forearm; Humans; Hypercholesterolemia; Hypertension; Insulin; Insulin Resistance; Lipoproteins, HDL; Peptides, Cyclic; Pioglitazone; PPAR gamma; Thiazolidinediones; Time Factors; Treatment Outcome; Triglycerides; Vasodilation | 2014 |
1 other study(ies) available for pioglitazone and bq 123
| Article | Year |
|---|---|
Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Bezafibrate; Cells, Cultured; DNA Primers; Dose-Response Relationship, Drug; Endothelin-1; Interleukin-18; Myocytes, Cardiac; NF-kappa B; Oligopeptides; Peptides, Cyclic; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Piperidines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Thiazolidinediones | 2008 |